too early for licensing deal (imo)
good to pay attention to what else is going on coz ATX doesn’t operate in a vacuum. Several FAK inhibitors in development, the one from Verastem oncology looks the most advanced. They also tout theirs as “best in class”!!
- Forums
- ASX - By Stock
- ATX
- Ann: Update on ACCENT Trial in Pancreatic Cancer
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-21
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.010(14.9%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
6.5¢ | 6.5¢ | 5.6¢ | $34.37K | 568.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18108 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 79035 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 18108 | 0.056 |
4 | 356818 | 0.055 |
2 | 26702 | 0.054 |
1 | 19607 | 0.051 |
3 | 83359 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 79035 | 2 |
0.060 | 86910 | 1 |
0.061 | 248803 | 1 |
0.062 | 40158 | 2 |
0.066 | 166989 | 2 |
Last trade - 13.44pm 20/06/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online